Seres Therapeutics Inc. (MCRB)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

Seres Therapeutics Inc. Forcast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for MCRB stock have an median target of 5.62, with a low estimate of 1.25 and a high estimate of 10. The median target predicts an increase of 538.64% from the current stock price of 0.88.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.25	$5.62	$5.62	$10
Change	42.05%	538.64%	538.64%	1036.36%

AI Analyst Report

Chardan Capital has reaffirmed a Buy rating on Ser... Unlock content with Pro Subscription

Updated Nov 13, 2024

Rating	May 24	Jun 24	Aug 24	Sep 24	Oct 24	Nov 24
Strong Buy	0	0	0	0	0	0
Buy	2	1	2	1	0	2
Hold	0	1	0	0	0	0
Sell	0	0	0	0	1	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	1	1	2

Financial Forecast this Year

Revenue This Year

25.83M

from 126.33M

-79.6%

from 126.33M

Revenue Next Year

10.50M

from 25.83M

-59.4%

from 25.83M

EPS This Year

-0.79

from -0.89

11.2%

from -0.89

EPS Next Year

-0.57

from -0.79

27.8%

from -0.79